Anti-Human NCR1 Therapeutic Antibody scFv Fragment
The antibody of is a non-depleting antibody that specifically target and therefore inhibit NKp46 in developing NK cell and cause an increase in the frequency of activated, reactive, cytotoxic and/or IFNy- producing NK cells in individual. Thus, the anti-NKp46 antibody can be applied in the treatment of breast cancer, leukemia, metastasis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0223CL-S(P) |
| Pricing | Inquiry |
| Type | Chimeric |
| Host | Human |
| Target | NKp46 |